Liabilities / Assets
82nd percentile
Higher debt load relative to assets than 82% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
82nd percentile
Higher debt load relative to assets than 82% of similar nonprofits.
Liabilities / Revenue
74th percentile
Higher debt load relative to revenue than 74% of similar nonprofits.
Net Margin
27th percentile
Higher net margin than 27% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
8th percentile
Faster asset growth than 8% of similar nonprofits.
Revenue Growth
27th percentile
Faster revenue growth than 27% of similar nonprofits.
Assets
Down$338,055
Down $108,704 (-24%) from 2015
Net Assets
Down$190,029
Down $46,193 (-20%) from 2015
Liabilities
Down$148,026
Down $62,511 (-30%) from 2015
Revenue
Down$744,901
Down $74,307 (-9.1%) from 2015
Expenses
Up$791,052
Up $39,270 (+5.2%) from 2015
Net Income
Down-$46,151
Down $113,577 (-168%) from 2015
This 2016 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
All activities for research and treatment of Cystic Fibrosis.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2016 • Form 990Summary only. Only limited summary data is available for this year.